Premenstrual Dysphoric Disorder (PMDD)
Yamada, K.
Seishin Shinkeigaku Zasshi 117(4): 292-298
2015
ISSN/ISBN: 0033-2658 PMID: 26524841 Document Number: 681663
Premenstrual dysphoric disorder (PMDD) is categorized as a subclass in depressive disorders of DSM-5. Speaking without fear of misunderstanding, my opinion is that patients with PMDD should be treated with medication, if there is no misdiagnosis as premenstrual syndrome (PMS). For the appropriate treatment of PMDD, it must be diagnosed accurately according to the DSM-5 criteria. The differential diagnosis and treatment of PMDD should be carried out by experienced psychiatrists.
Document emailed within 1 workday
Related Documents
Schiola, A.; Lowin, J.; Lindemann, M.; Patel, R.; Endicott, J. 2011: The burden of moderate/severe premenstrual syndrome and premenstrual dysphoric disorder in a cohort of Latin American women Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 14(5 Suppl. 1): S93-S95Freeman, E.W.; Halbreich, U.; Grubb, G.S.; Rapkin, A.J.; Skouby, S.O.; Smith, L.; Mirkin, S.; Constantine, G.D. 2012: An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome Contraception 85(5): 437-445
Freeman, E.W.; Rickels, K.; Sondheimer, S.J. 1996: Fluvoxamine for premenstrual dysphoric disorder: a pilot study Journal of Clinical Psychiatry 57(Suppl): 56-59
Kelderhouse, K.; Taylor, J.S. 2013: A review of treatment and management modalities for premenstrual dysphoric disorder Nursing for Women's Health 17(4): 294-305
Pearlstein, T.B.; Stone, A.B.; Lund, S.A.; Scheft, H.; Zlotnick, C.; Brown, W.A. 1997: Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder Journal of Clinical Psychopharmacology 17(4): 261-266
Rojnić Kuzman, M.; Hotujac, L. 2007: Premenstrual dysphoric disorder--a neglected diagnosis? Preliminary study on a sample of Croatian students Collegium Antropologicum 31(1): 131-137
Qiao, M.; Sun, P.; Wang, H.; Wang, Y.; Zhan, X.; Liu, H.; Wang, X.; Li, X.; Wang, X.; Wu, J.; Wang, F. 2017: Epidemiological Distribution and Subtype Analysis of Premenstrual Dysphoric Disorder Syndromes and Symptoms Based on TCM Theories Biomed Research International 2017: 4595016
Young, S.A.; Hurt, P.H.; Benedek, D.M.; Howard, R.S. 1998: Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial Journal of Clinical Psychiatry 59(2): 76-80
Marr, J.; Niknian, M.; Shulman, L.P.; Lynen, R. 2011: Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3 mg administered in a 24/4 regimen Contraception 84(1): 81-86
Harrison, W.M.; Endicott, J.; Rabkin, J.G.; Nee, J. 1984: Treatment of premenstrual dysphoric changes: clinical outcome and methodological implications Psychopharmacology Bulletin 20(1): 118-122
Kouri, E.M.; Halbreich, U. 1997: State and trait serotonergic abnormalities in women with dysphoric premenstrual syndromes Psychopharmacology Bulletin 33(4): 767-770
Segebladh, B.; Borgström, A.; Odlind, V.; Bixo, M.; Sundström-Poromaa, I. 2009: Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives Contraception 79(1): 50-55
Sharma, V.; Persad, E.; Mazmanian, D. 1993: Dysphoric or mixed mania American Journal of Psychiatry 150(12): 1907-1909
Berardi, D.; Zanfini, R.; Alessi, S.; Giannelli, A.; Ferrari, G. 1993: Neuroleptic-induced dysphoric response in non-schizophrenic patients Minerva Psichiatrica 34(2): 125-133
Whittier, M.C.; West, S.A.; Galli, V.B.; Raute, N.J. 1995: Valproic acid for dysphoric mania in a mentally retarded adolescent Journal of Clinical Psychiatry 56(12): 590-591
Carlsson, C.; Pettersson, L. 1972: Dysphoric symptoms in chronic alcoholics and the effect of carbamazepine (Tegretol) Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 5(4): 403-405
Zharikov, M.N. 1984: Features of dysphoric states developing within the framework of endogenous depression Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 84(12): 1844-1848
Kapfhammer, H.P.; Dobmeier, P.; Mayer, C.; Rothenhäusler, H.B. 1998: Conversion syndromes in neurology. a psychopathological and psychodynamic differentiation of conversion disorder, somatization disorder and factitious disorder Psychotherapie Psychosomatik Medizinische Psychologie 48(12): 463-474
Williams, J.B.; Spitzer, R.L. 1982: Idiopathic pain disorder: a critique of pain-prone disorder and a proposal for a revision of the DSM-III category psychogenic pain disorder Journal of Nervous and Mental Disease 170(7): 415-419
Cardona-Castrillon, G.P.; Isaza, R.; Zapata-Soto, A.P.; Franco, J.G.; Gonzalez-Berrio, C.; Tamayo-Diaz, C.P. 2007: The comorbidity of major depressive disorder, dysthymic disorder and anxiety disorders with migraine Revista de Neurologia 45(5): 272-275